Nuzenio

Mesothelioma Study

Mesothelioma Study news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Australian company points to encouraging survival signal in mesothelioma CAR-T study - BiotechDispatchBiotechDispatch · Mon, 10 Aug 2026 08:35:18 GMT Mesothelioma Patient Remains Cancer-Free Two Years After Single CAR T Cell Treatment - Mesothelioma.netMesothelioma.net · Wed, 05 Aug 2026 15:29:01 GMT AdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMT AdAlta Reports Two-Year Survival Milestone for First EW-001 Complete Responder in Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:55:33 GMT AdAlta (ASX:1AD) Reports Two-Year Cancer-Free Survival Milestone in EW-001 Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:17:00 GMT New Study Probes Immunotherapy Before and After Mesothelioma Surgery - Mesothelioma GuideMesothelioma Guide · Tue, 04 Aug 2026 12:30:52 GMT Study Shows Staggering End-of-Life Cancer Costs – Mesothelioma Among Highest - Mesothelioma.netMesothelioma.net · Mon, 03 Aug 2026 14:14:48 GMT Mesothelioma Applied Research Foundation Awards Record $850,000 in Research Grants - Mesothelioma.netMesothelioma.net · Wed, 29 Jul 2026 14:17:41 GMT

Timeline

Mon, 10 Aug 2026 08:35:18 GMTAustralian company points to encouraging survival signal in mesothelioma CAR-T study - BiotechDispatch

Wed, 05 Aug 2026 15:29:01 GMTMesothelioma Patient Remains Cancer-Free Two Years After Single CAR T Cell Treatment - Mesothelioma.net

Wed, 05 Aug 2026 09:32:35 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatch

Wed, 05 Aug 2026 00:55:33 GMTAdAlta Reports Two-Year Survival Milestone for First EW-001 Complete Responder in Mesothelioma Study - Kalkine

Wed, 05 Aug 2026 00:17:00 GMTAdAlta (ASX:1AD) Reports Two-Year Cancer-Free Survival Milestone in EW-001 Mesothelioma Study - Kalkine

Tue, 04 Aug 2026 12:30:52 GMTNew Study Probes Immunotherapy Before and After Mesothelioma Surgery - Mesothelioma Guide

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Mesothelioma8 live mentions CAR2 live mentions BiotechDispatch BiotechDispatch2 live mentions Mesothelioma Patient Remains2 live mentions Cancer2 live mentions Free Two Years2 live mentions After Single CAR2 live mentions T Cell Treatment2 live mentions AdAlta2 live mentions Year Survival Milestone2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mesothelioma Study.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.